5-((tert-Butyldimethylsilyl)oxy)pentanoic acid, 97%, 100mg

4-chloro-6-methyl-5-phenylthieno[2,3-d]pyrimidine, 95.0%, 500mg

N-(2,4,6-Trimethylphenyl)-2-chloropropanamide, 97%, 2g

4-((5-Methylpyrazin-2-yl)amino)quinazolin-6-ol, 90%, 100mg

1H-PYRAZOLO[4,3-C]PYRIDINE-6-CARBOXYLIC ACID, 3-BROMO-, METHYL ESTER, 93%, 250mg

3-(3-Methoxyphenyl)-3-oxopropanenitrile, 95.0%, 10g

2-(2-Bromophenyl)-2-methylpropanenitrile, 95.0%, 5g

Símbolo de advertencia según ISO 7010 Etiqueta individual, Superficie caliente, Longitud lateral 200 mm, 1 pieza

4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 97.0%, 500mg

1-Methoxy-4-(prop-2-yn-1-yloxy)benzene, 95%, 5g

4-Chloro-1-methyl-1H-pyrrolo[3,2-c]pyridine, 97.0%, 100mg

2'-BROMO-3',4'-DIFLUOROACETOPHENONE, 95.0%, 5g

2-Methoxyphenoxyacetic Acid>98.0%(T)25g